Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2024 · 105 positions · Total reported value $2.62B · Top-10 concentration 36.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Rock Springs Capital Management LP disclosed 105 equity positions with a combined reported value of $2.62B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 36.4% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were ARGX ($141.20M), ISRG ($112.74M), LLY ($111.55M). By sector, the heaviest allocations are Health Care 82.5%, Consumer Discretionary 2.8%. Versus the prior quarter, allocation shifted toward Health Care (+1.0pp) and away from Consumer Discretionary (-0.8pp).

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 81% of names.

The largest new positions opened in Q4 2024 were SRRK ($30.98M), THC ($16.31M), JANX ($10.95M).

Of the 8 positions fully exited versus the prior quarter, the largest were HUM ($46.88M), ALGN ($29.12M), NVO ($15.72M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • SRRK SCHOLAR ROCK HLDG CORP · $30.98M
  • THC TENET HEALTHCARE CORP · $16.31M
  • JANX JANUX THERAPEUTICS INC · $10.95M
  • ARDX ARDELYX INC · $7.42M
  • TARS TARSUS PHARMACEUTICALS INC · $6.14M
  • SLNO SOLENO THERAPEUTICS INC · $5.58M
  • ETNB 89BIO INC · $4.32M
  • NGNE NEUROGENE INC · $2.18M

Fully Exited (vs previous quarter)

  • HUM HUMANA INC · prev qtr: $46.88M
  • ALGN ALIGN TECHNOLOGY INC · prev qtr: $29.12M
  • NVO NOVO-NORDISK A S · prev qtr: $15.72M
  • JNJ JOHNSON & JOHNSON · prev qtr: $12.96M
  • CYTK CYTOKINETICS INC · prev qtr: $10.88M · history
  • BMRN BIOMARIN PHARMACEUTICAL INC · prev qtr: $10.61M
  • KRYS KRYSTAL BIOTECH INC · prev qtr: $10.17M
  • AUPH AURINIA PHARMACEUTICALS INC · prev qtr: $8.65M

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 104 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 44.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
  • Average position size: $19.70M

Sector Tilt

  • Health Care 96.8%
  • Industrials 1.1%
  • Consumer Discretionary 1.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 82.5%
Technology 0.9%
Materials 0.1%
Other 11.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 229.60K $141.20M 5.39%
5.39%
Reduce
2 216.00K $112.74M 4.30%
4.30%
Reduce
3 144.50K $111.55M 4.26%
4.26%
Add
4 720.50K $98.35M 3.75%
3.75%
Reduce
5 1.10M $95.67M 3.65%
3.65%
Add
6 176.00K $89.03M 3.40%
3.40%
Reduce
7 4.97M $86.64M 3.31%
3.31%
Add
8 265.21K $81.84M 3.12%
3.12%
Add
9 1.74M $73.19M 2.79%
2.79%
Reduce
10 1.16M $65.09M 2.48%
2.48%
Reduce
11 1.47M $60.85M 2.32%
2.32%
Reduce
12 256.20K $60.29M 2.30%
2.30%
Add
13 240.00K $57.00M 2.17%
2.17%
Reduce
14 168.75K $55.28M 2.11%
2.11%
Add
15 1.21M $53.07M 2.02%
2.02%
Add
16 2.04M $51.33M 1.96%
1.96%
Reduce
17 1.25M $49.07M 1.87%
1.87%
Reduce
18 327.50K $48.51M 1.85%
1.85%
Reduce
19 305.00K $41.99M 1.60%
1.60%
Reduce
20 1.03M $41.60M 1.59%
1.59%
Reduce
21 460.00K $41.09M 1.57%
1.57%
Hold
22 545.00K $40.35M 1.54%
1.54%
Reduce
23 550.00K $37.97M 1.45%
1.45%
Reduce
24 892.55K $37.53M 1.43%
1.43%
Hold
25 307.50K $37.39M 1.43%
1.43%
Hold
26 397.50K $35.84M 1.37%
1.37%
Hold
27 1.31M $34.19M 1.30%
1.30%
Reduce
28 429.99K $33.66M 1.28%
1.28%
Hold
29 9.60M $33.60M 1.28%
1.28%
Add
30 716.78K $30.98M 1.18%
1.18%
New
31 1.22M $30.88M 1.18%
1.18%
Add
32 114.25K $29.83M 1.14%
1.14%
Reduce
33 1.08M $29.32M 1.12%
1.12%
Add
34 353.00K $27.45M 1.05%
1.05%
Reduce
35 946.50K $26.33M 1.00%
1.00%
Add
36 450.00K $25.29M 0.96%
0.96%
Reduce
37 2.60M $24.49M 0.93%
0.93%
Add
38 130.00K $24.10M 0.92%
0.92%
Hold
39 475.00K $23.75M 0.91%
0.91%
Reduce
40 2.06M $23.18M 0.88%
0.88%
Hold
41 583.50K $23.14M 0.88%
0.88%
Reduce
42 909.10K $22.52M 0.86%
0.86%
Reduce
43 920.00K $22.27M 0.85%
0.85%
Reduce
44 487.86K $20.63M 0.79%
0.79%
Add
45 2.68M $20.14M 0.77%
0.77%
Reduce
46 767.52K $19.73M 0.75%
0.75%
Add
47 1.05M $18.81M 0.72%
0.72%
Add
48 2.55M $18.79M 0.72%
0.72%
Reduce
49 512.13K $16.66M 0.64%
0.64%
Add
50 129.20K $16.31M 0.62%
0.62%
New

FAQ

What did Rock Springs Capital Management LP buy in 2024-Q4?

In its 2024-Q4 13F filing, Rock Springs Capital Management LP reported 105 equity positions worth $2.62B in aggregate; its largest disclosed positions were ARGX ($141.20M), ISRG ($112.74M), LLY ($111.55M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $2.62B of long equity holdings across 105 positions as of 2024-Q4. Top-10 holdings account for 36.4% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →